News
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
StockStory.org on MSN17h
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
2d
Barchart on MSNWhat to Expect From Moderna's Next Quarterly Earnings ReportModerna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...
Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...
Pioneer in RNA research who gave children with SMA a future Sabine Löwer Communications Boehringer Ingelheim St ...
Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...
Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA approved assay for solid tumor testing. The test, ...
A new large study from Denmark finds no evidence that aluminum salts used in vaccines are tied to a higher risk of childhood ...
Under the agreement, Allarity will supply advanced transcriptome analysis services to support the partner’s efforts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results